$300 million raised for COVAX vaccine sharing at GAVI event: US

The US will contribute an additional $2 billion to the vaccines alliance Gavi through 2022

$300 million raised for COVAX vaccine sharing at GAVI event: US
Representative image
Reuters
1 min read Last Updated : Apr 15 2021 | 11:08 PM IST
A fund-raising event organised by the Gavi vaccine alliance and the United States secured more than $300 million in fresh funds and Covid-19 doses for the COVAX vaccine-sharing facility, USAID Acting Administrator Gloria Steele said on Thursday.
 
"Investment in COVAX is a prerequisite for recovery ...ending the acute phase of the pandemic is currently the best economic decision for any country," Jose Manuel Barroso, chair of the Gavi vaccine alliance, said after the three-hour event hosted by the organisation.
 
US to contribute $2 billion
 

Also Read

The US will contribute an additional $2 billion to the vaccines alliance Gavi through 2022 in support of the global COVAX initiative so that people everywhere can have access to safe and effective vaccines, Secretary of State Antony Blinken announced on Thursday and called on partners to aid urgent vaccine manufacturing, supply and delivery needs.
 
"It will contribute an additional $2 billion to this effort through 2022, because people everywhere should have access to rigorously tested, safe, and effective Covid- 19 vaccines," Blinken said.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineUS funding

Next Story